Given the technical challenges and ethical concerns associated with brain tissue sequencing, constructing model to predict the expression levels of JAM2 in target brain tissues holds potential clinical diagnostic value for PFBC. This evidence concerns the gene JAM2 and bilateral striopallidodentate calcinosis.